C Demacq
Overview
Explore the profile of C Demacq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franca E, Ishitani L, Carneiro M, Machado I, Nascimento B, Martins-Melo F, et al.
Public Health
. 2023 Dec;
227:112-118.
PMID: 38157737
Objectives: The objective of this study was to identify Brazil's most critical garbage codes (GCs) reclassified to Chagas disease (ChD) in mortality data and their proportions. We also estimated the...
2.
de Haro Moraes C, Figueiredo V, de Faria A, Barbaro N, Sabbatini A, Quinaglia T, et al.
J Hum Hypertens
. 2012 Jul;
27(4):225-30.
PMID: 22810172
Leptin and aldosterone have been associated with the pathophysiological mechanisms of hypertension. However, despite studies showing the association of leptin with intima-media thickness, arterial distensibility and sympathetic nerve activation, the...
3.
Quinaglia T, Martins L, Figueiredo V, Santos R, Yugar-Toledo J, Martin J, et al.
J Hum Hypertens
. 2011 May;
25(11):656-64.
PMID: 21544090
Resistant hypertension (RHTN) includes both patients whose blood pressure (BP) is uncontrolled on three or more medications (uncontrolled RHTN (UCRH)) and patients whose BP is controlled with use of four...
4.
Martins L, Figueiredo V, Quinaglia T, Boer-Martins L, Yugar-Toledo J, Martin J, et al.
J Hum Hypertens
. 2010 Oct;
25(9):532-8.
PMID: 20927128
Resistant hypertension (RHTN) includes patients whose blood pressure (BP) is controlled with the use of four or more antihypertensive medications, and is referred to as 'controlled resistant hypertension' (CRH). While...
5.
Demacq C, Vasconcellos V, Marcaccini A, Gerlach R, Machado A, Tanus-Santos J
Pharmacogenomics J
. 2009 Apr;
9(4):265-73.
PMID: 19381161
We examined whether two functional polymorphisms (g.-1562C>T and g.-90(CA)14-24) in the matrix metalloproteinase (MMP)-9 gene or MMP-9 haplotypes affect the circulating levels of pro-MMP-9 and pro-MMP-9/TIMP-1 (tissue inhibitor of metalloproteinase-1)...